Gupta Richie, Gupta Rajat, Puri Anurag
Department of Plastic, Aesthetic and Reconstructive Surgery and Gender Identity Clinic, Fortis Hospital, Shalimar Bagh, Delhi, India.
Department of Urology and Kidney Transplant, Fortis Hospital, Shalimar Bagh, Delhi, India.
Indian J Plast Surg. 2022 Jul 18;55(2):196-204. doi: 10.1055/s-0042-1749104. eCollection 2022 Apr.
Masculinizing genital gender affirmation surgery (MgGAS) consists of operative procedures designed to help the transition of transmen in their journey toward male gender role. Phalloplasty and urethral lengthening remain the most challenging of these surgeries, as the female urethra (4 cm long) must be lengthened to male dimensions (15-29 cm) with anastomosis at two sites, the native urethra/pars fixa urethra and the pars fixa urethra-penile urethra. As a result, there is a high incidence of urinary complications such as strictures and fistulae. Authors incorporated a urethral lengthening technique to reduce urinary complications in MgGAS. They compare the rates of urinary complications rates in cohorts before and after the introduction of this technique. Authors have been performing phalloplasty since past 27 years, utilizing mainly free radial artery forearm flap (fRAFFp 431 cases) and pedicled anterolateral thigh flap (pALTp 120 cases). A retrospective review and comparison of urinary complications were performed before and after the introduction of their new technique since March 2017. There was a statistically significant reduction in the incidence of stricture with and without fistulae (25.94% with conventional and 4.17% with urethral lengthening technique = 0.001) and fistulae alone (12.81% with conventional and 2.78% with urethral lengthening technique = 0.011) in fRAFFp cases. In pALTp cases, the respective reductions were 43.08 to 17.07%, = 0.006 (significant), and 13.85 to 4.88%, = 0.197 (not statistically significant). Over years, the rates of urinary complications in MgGAS have remained constant, varying from 25 to 58% for strictures and 17 to 75% for fistulae as noted by many authors. Authors noted that in most of their cases, strictures occurred at distal pars fixa urethra (DPFU)-penile urethra anastomosis and incorporated a urethral lengthening technique, which lengthens the DPFU by 3 to 5 cm at this anastomotic site, thus significantly reducing the anastomotic tension and the rate of urinary complications.
男性化生殖器性别确认手术(MgGAS)包括一系列手术操作,旨在帮助跨性别男性向男性性别角色转变。阴茎再造术和尿道延长术仍然是这些手术中最具挑战性的,因为女性尿道(4厘米长)必须延长至男性尺寸(15 - 29厘米),并在两个部位进行吻合,即原生尿道/尿道固定部以及尿道固定部 - 阴茎尿道。因此,诸如尿道狭窄和瘘管等泌尿系统并发症的发生率很高。作者采用了一种尿道延长技术以减少MgGAS中的泌尿系统并发症。他们比较了引入该技术前后队列中的泌尿系统并发症发生率。
作者在过去27年中一直在进行阴茎再造术,主要使用游离桡动脉前臂皮瓣(fRAFFp,431例)和带蒂股前外侧皮瓣(pALTp,120例)。自2017年3月引入新技术前后,对泌尿系统并发症进行了回顾性分析和比较。
在fRAFFp病例中,伴有或不伴有瘘管的尿道狭窄发生率有统计学显著降低(传统方法为25.94%,尿道延长技术为4.17%,P = 0.001),单独瘘管发生率也有显著降低(传统方法为12.81%,尿道延长技术为2.78%,P = 0.011)。在pALTp病例中,相应的降低分别为43.08%至17.07%,P = 0.006(显著),以及13.85%至4.88%,P = 0.197(无统计学意义)。
多年来,MgGAS中泌尿系统并发症的发生率一直保持不变,正如许多作者所指出的,尿道狭窄发生率在25%至58%之间,瘘管发生率在17%至75%之间。作者指出,在他们的大多数病例中,狭窄发生在尿道固定部远端(DPFU) - 阴茎尿道吻合处,并采用了一种尿道延长技术,该技术在这个吻合部位将DPFU延长3至5厘米,从而显著降低吻合张力和泌尿系统并发症的发生率。